An Open-label Phase 2a Clinical Trial to Test the Effect of Yellow Fever Vaccination in a Background of Japanese Encephalitis Antibodies.
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2016
Price : $35 *
At a glance
- Drugs Yellow fever vaccine (Primary) ; IC 51
- Indications Japanese encephalitis; Yellow fever
- Focus Pharmacodynamics
- 19 Apr 2016 Status changed from active, no longer recruiting to completed.
- 01 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.